Table 1. Comparision of the R3T One-Step qRT-PCR System with the Invitrogen Superscript III Platinum One-Step qRT-PCR Systema.
R3T one-step qRT-PCR
system |
Invitrogen superscript
III platinum one-step qRT-PCR system |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sr. nos. | sample | N1 | N2 | RP | expected | result | sr. nos. | sample | N1 | N2 | RP | expected | result |
1 | 613 | 16.9 | 17.5 | 27.3 | + | positive SARS CoV-2 | 1 | 613 | 17.5 | 17.3 | 27.2 | + | positive SARS CoV-2 |
2 | 632 | 17.8 | 18.6 | 27.9 | + | positive SARS CoV-2 | 2 | 632 | 18.5 | 18.6 | 27.9 | + | positive SARS CoV-2 |
3 | 581 | 20.5 | 21.8 | 25.1 | + | positive SARS CoV-2 | 3 | 581 | 21.6 | 22.1 | 25.3 | + | positive SARS CoV-2 |
4 | 599 | 22.1 | 23.6 | 23.9 | + | positive SARS CoV-2 | 4 | 599 | 23.2 | 23.7 | 23.9 | + | positive SARS CoV-2 |
5 | 583 | 24.5 | 25.7 | 25.8 | + | positive SARS CoV-2 | 5 | 583 | 25.9 | 26.1 | 26.3 | + | positive SARS CoV-2 |
6 | 572 | 27.0 | 28.3 | 24.6 | + | positive SARS CoV-2 | 6 | 572 | 28.5 | 29.0 | 28.8 | + | positive SARS CoV-2 |
7 | 562 | 30.0 | 30.6 | 28.4 | + | positive SARS CoV-2 | 7 | 562 | 29.5 | 30.0 | 27.3 | + | positive SARS CoV-2 |
8 | 291 | 26.9 | 29.0 | 23.7 | + | positive SARS CoV-2 | 8 | 291 | 29.8 | 31.3 | 24.5 | + | positive SARS CoV-2 |
9 | 380 | 27.1 | 27.4 | 23.5 | + | positive SARS CoV-2 | 9 | 380 | 26.8 | 27.1 | 24.4 | + | positive SARS CoV-2 |
10 | 550 | 32.8 | 33.1 | 26.9 | + | positive SARS CoV-2 | 10 | 550 | 33.0 | 33.9 | 26.3 | + | positive SARS CoV-2 |
11 | 552 | 32.6 | 35.4 | 30.7 | + | positive SARS CoV-2 | 11 | 552 | 34.2 | 34.7 | 30.2 | + | positive SARS CoV-2 |
12 | 554 | 33.9 | 35.0 | 31.9 | + | positive SARS CoV-2 | 12 | 554 | 33.2 | 33.4 | 28.6 | + | positive SARS CoV-2 |
13 | 585 | 35.5 | 38.4 | 24.1 | + | positive SARS CoV-2 | 13 | 585 | 35.4 | 37.6 | 23.3 | + | positive SARS CoV-2 |
14 | 600 | 35.3 | 38.3 | 26.2 | + | positive SARS CoV-2 | 14 | 600 | 35.9 | 37.2 | 26.3 | + | positive SARS CoV-2 |
15 | 601 | 34.6 | 36.7 | 23.4 | + | positive SARS CoV-2 | 15 | 601 | 35.2 | 36.1 | 23.0 | + | positive SARS CoV-2 |
16 | 745 | 34.0 | 37.0 | 28.1 | + | positive SARS CoV-2 | 16 | 745 | 35.3 | 36.7 | 28.1 | + | positive SARS CoV-2 |
17 | 748 | 31.3 | 33.4 | 27.0 | + | positive SARS CoV-2 | 17 | 748 | 32.1 | 34.1 | 26.9 | + | positive SARS CoV-2 |
18 | 749 | 34.3 | 36.1 | 32.9 | + | positive SARS CoV-2 | 18 | 749 | 34.1 | 34.7 | 32.5 | + | positive SARS CoV-2 |
19 | 751 | 35.0 | 37.2 | 29.6 | + | positive SARS CoV-2 | 19 | 751 | 34.9 | 36.1 | 28.6 | + | positive SARS CoV-2 |
20 | 750 | 34.5 | 38.3 | 37.6 | + | positive SARS CoV-2 | 20 | 750 | 35.2 | 36.8 | 36.7 | + | positive SARS CoV-2 |
21 | 411 | – | – | 27.5 | – | negative SARS CoV-2 | 21 | 411 | 36.9 | – | 29.1 | – | negative SARS CoV-2 |
22 | 429 | – | – | 26.9 | – | negative SARS CoV-2 | 22 | 429 | 39.3 | 40.5 | 27.5 | – | negative SARS CoV-2 |
23 | 440 | – | – | 25.1 | – | negative SARS CoV-2 | 23 | 440 | 37.6 | – | 25.5 | – | negative SARS CoV-2 |
24 | + | 24.8 | 25.1 | 24.8 | – | positive control | 24 | + | 23.6 | 23.6 | 24.2 | – | positive control |
25 | NTC | – | – | – | – | not detected | 25 | NTC | – | – | – | – | not detected |
N1 and N2: N-gene: RP: RNaseP; NTC: no template.